Study questions increasing cost of intensive care of pneumocystis. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Study questions increasing cost of intensive care of pneumocystis. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

AIDS Policy Law. 1995 Feb 10;10(2):2. Unique Identifier : AIDSLINE AIDS/95700162

Abstract: According to a new study, intensive care for AIDS patients with severe pneumonia is becoming so expensive that policy makers may decide to ration or refuse treatments. Researchers at the University of California-San Francisco (UCSF) found that it costs an average of $215,000 to extend by one year the life of an AIDS patient who is treated for pneumocystis carinii pneumonia (PCP) in a hospital's intensive care unit. This is twice as much as comparable care cost in 1988. AIDS patients are surviving longer, with some suffering their second or third PCP infection, increasing the cost. Researchers were careful to note that rationing health care means certain death for some AIDS patients with PCP.

Keywords: AIDS-Related Opportunistic Infections/NURSING/*THERAPY Cost-Benefit Analysis *Health Care Costs Health Care Rationing/LEGISLATION & JURISPRUD Health Policy Human Intensive Care/*ECONOMICS Pneumonia, Pneumocystis carinii/NURSING/*THERAPY Quality of Life NEWSLETTER ARTICLE
950930
M9591297

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .